Navigation Links
Galil Medical Announces Reimbursement for Small Renal Cancer Cryoablation in Japan
Date:8/9/2011

ARDEN HILLS, Minnesota, August 9, 2011 /PRNewswire/ --

 

- Cryotherapy Continues to Grow as the Treatment of Choice for Renal Tumors Around the World

Galil Medical, a global leader in minimally invasive cryotherapy treatments, announced today that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved reimbursement for small renal cancer cryoablation using a percutaneous approach, as well as under open or endoscopic surgery.

 "We appreciate the MHLW reimbursement decision as this will allow Japanese patients to have greater access to renal cryoablation and benefit from Galil's advanced technology," commented Martin Emerson, Galil Medical President and CEO.

Galil Medical's CryoHit/SeedNet for MRI received approval for small renal tumor cryoablation under MRI-guidance in January 2010 from the MHLW. The regulatory and reimbursement approval processes have been spearheaded by Hitachi Medical Corporation, Galil Medical's exclusive distribution partner in Japan.

Cryotherapy is a minimally invasive procedure that uses extreme cold to freeze and destroy tumors. Visualization with MR imaging monitors the ablation zone of the tumor and minimizes impact to healthy adjacent tissue.

Standard treatment options for renal cancer include total and partial nephrectomy, open and laparoscopic procedures.  Minimally invasive ablative therapies, such as percutaneous cryotherapy, are increasingly accepted treatment options due to favorable clinical outcomes, reduced procedural pain, fewer complications and faster patient recovery. 

About Galil Medical Galil Medical is a global leader in delivering innovative cryotherapy solutions. The company is addressing patient conditions across multiple physician specialties; treatment areas include conditions affecting bone, kidney, liver, lung and prostate, as well as targeted pain and nerve applications. Company offices are located in Arden Hills, Minnesota; Yokneam, Israel; and London, United Kingdom. Shareholders include Thomas, McNerney & Partners, The Vertical Group, and Investor Growth Capital.

Contact information:

Pam Schwartz
Asia Pacific Manager
Galil Medical
T: +972-4-909-3273
M: +972-52-625-4443
F: +972-4-959-1077
pam.schwartz@galilmedical.com

Lisa Hayden
Vice President, Global Reimbursement
Galil Medical
T: +1-877-639-2796 option #4
M: +1-703-209-7774
F: +1-651-287-5125
lisa.hayden@galilmedical.com



'/>"/>
SOURCE Galil Medical Ltd
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Galil Medical Announces Establishment of Global Headquarters in Minneapolis, MN
2. Endo Pharmaceuticals Reports Second Quarter Revenues and Updates Financial Guidance, Reflecting the Acquisition of American Medical Systems
3. Healthcare Practices Considering Outsourcing Their Medical Typing Requirements - Med Data Care Pro, an Ideal Choice
4. Carrot Medical Positioned for Third Straight Year of Triple Digit Growth
5. Auxilium Pharmaceuticals, Inc. Announces Promotion of Dr. James P. Tursi to Chief Medical Officer
6. Saladax Biomedical, Inc. Enters Agreement with Kaan Medikal for Distribution of My5-FU in Turkey
7. Researchers Find RapidArc® Radiotherapy from Varian Medical Systems Can Quickly and Accurately Deliver Total Marrow Irradiation (TMI) Treatments for Patients with Blood Cancers
8. China Medical Technologies and Leica Microsystems Announce Collaboration
9. David J. Illingworth Appointed to Board of Directors for Varian Medical Systems
10. South Florida Radiation Oncology on the Forefront of Cancer Treatment with the TrueBeam™ Radiotherapy System from Varian Medical Systems
11. China Sky One Medical Announces Conference Call to Discuss Second Quarter 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... Jan. 20, 2017  Today, during a ... "PI3K Pathways in Immunology, Growth Disorders and ... INFI ) presented preclinical data ... that selectively inhibits phosphoinositide-3-kinase-gamma (PI3K-gamma). Preclinical data ... overcome resistance to checkpoint inhibition by remodeling ...
(Date:1/20/2017)... Research and Markets has announced the addition of the ... Amplifiers, Diagnostic Instruments), Sales Volume, Company Analysis and Forecast to ... ... Volume, Company Analysis and Forecast to 2022 provides a comprehensive ... The growing prevalence of hearing impairment coupled with an expanding ...
(Date:1/20/2017)... 2017  Palladian Health, a leading provider of ... of an opioid management program which assists physicians ... helps stem the growing tide of dependence on ... chronic non-cancer pain (back pain, neck pain, and ... of evidence regarding long-term effectiveness. The ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... 20, 2017 , ... Vitamin Well has launched two new ... have been produced in collaboration with Zlatan Ibrahimovic and have been developed to ... a successful launch in Sweden last year, the next generation sports drinks VW+001 ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Code Word: Chocolate Biscuit”: a biographical account following a man ... is the creation of published author, Marlyn Ivey, born in Lynn Haven, Florida and at ... school and at 19 years of age, he joined the Navy and got married right ...
(Date:1/20/2017)... ... 20, 2017 , ... “Christmas in Suffolk”: a story of love, secrets, ... lives in Lafayette, Indiana where she works in a daycare and looks for inspiration ... Published by Christian Faith Publishing, Sara Seymour’s new book is an adventure of love ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Land of More and ... the issue of world hunger, and shares the simple and achievable answer. “The Land ... and member of the Fairview Missionary Church in Angola, Indiana where he works with ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... On-demand E-learning system for Clinical and Regulatory education for Physicians, Physician Advisors, ... Aerolib`s successful education methodology of Disease Specific Documentation Improvement. , The Aerolib ...
Breaking Medicine News(10 mins):